Steven M Haffner Selected Research

Steven M Haffner Research Topics

Disease

86	Insulin Resistance 11/2017 - 04/2002
68	Type 2 Diabetes Mellitus (MODY) 09/2021 - 04/2002
41	Atherosclerosis 11/2017 - 04/2002
35	Glucose Intolerance 05/2017 - 04/2002
32	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2014 - 01/2002
26	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 04/2002
23	Obesity 08/2015 - 07/2002
18	Hypertension (High Blood Pressure) 04/2014 - 07/2002
12	Myocardial Infarction 01/2018 - 06/2002
12	Inflammation (Inflammations) 11/2017 - 04/2002
10	Stroke (Strokes) 01/2018 - 04/2006
10	Dyslipidemias (Dyslipidemia) 07/2007 - 07/2002
9	Heart Failure 01/2018 - 12/2006
9	Weight Loss (Weight Reduction) 08/2015 - 07/2003
5	Chronic Renal Insufficiency 10/2020 - 05/2009
5	Overweight 08/2015 - 07/2011
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 05/2009
4	Weight Gain 01/2010 - 03/2005
4	Abdominal Obesity 09/2007 - 11/2003
4	Thrombosis (Thrombus) 04/2006 - 11/2003
3	Atrial Fibrillation 11/2013 - 01/2012
3	Coronary Disease (Coronary Heart Disease) 09/2013 - 04/2002
3	Prediabetic State (Prediabetes) 04/2013 - 10/2003
3	Hypertriglyceridemia 10/2012 - 10/2005
3	Unstable Angina 04/2010 - 08/2002
3	Diabetes Mellitus 04/2010 - 04/2002
3	Hyperglycemia 06/2004 - 07/2003
2	Renal Insufficiency (Renal Failure) 01/2017 - 12/2012
2	Body Weight (Weight, Body) 11/2013 - 09/2007
2	Metabolic Diseases (Metabolic Disease) 01/2013 - 07/2007
2	Hypoglycemia (Reactive Hypoglycemia) 04/2010 - 12/2006
2	Hemorrhage 05/2009 - 04/2009
2	Hyperinsulinism (Hyperinsulinemia) 12/2007 - 11/2003
2	Non-alcoholic Fatty Liver Disease 06/2006 - 11/2005

Drug/Important Bio-Agent (IBA)

87	Glucose (Dextrose)FDA LinkGeneric 03/2017 - 04/2002
44	Insulin (Novolin)FDA Link 03/2017 - 04/2002
24	C-Reactive ProteinIBA 03/2017 - 04/2002
21	Triglycerides (Triacylglycerol)IBA 12/2015 - 09/2002
20	HDL CholesterolIBA 12/2015 - 10/2002
20	CholesterolIBA 01/2012 - 01/2002
14	Valsartan (Vals)FDA Link 05/2017 - 10/2008
13	Fibrinogen (Factor I)FDA Link 07/2011 - 04/2002
12	Nateglinide (Starlix)FDA LinkGeneric 05/2017 - 10/2008
11	Plasminogen Activators (Plasminogen Activator)IBA 11/2014 - 04/2002
10	LipidsIBA 11/2013 - 07/2003
9	CreatinineIBA 01/2017 - 06/2005
9	LDL CholesterolIBA 09/2013 - 10/2002
8	AdiponectinIBA 08/2015 - 12/2003
8	Plasminogen Activator Inhibitor 1IBA 11/2014 - 04/2002
8	Rosiglitazone (Avandia)FDA Link 05/2011 - 08/2002
8	Metformin (Glucophage)FDA LinkGeneric 05/2011 - 10/2002
7	Lipoproteins (Lipoprotein)IBA 12/2015 - 10/2002
6	aliskiren FDA Link 10/2020 - 05/2009
6	Biomarkers (Surrogate Marker)IBA 02/2015 - 06/2006
6	Pharmaceutical PreparationsIBA 04/2014 - 10/2002
6	AlbuminsIBA 03/2013 - 10/2002
6	Glyburide (Glibenclamide)FDA LinkGeneric 05/2011 - 10/2002
5	Antihypertensive Agents (Antihypertensives)IBA 12/2008 - 09/2002
4	Angiotensin Receptor AntagonistsIBA 10/2012 - 05/2006
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2009 - 09/2005
4	Clopidogrel (Plavix)FDA Link 05/2009 - 09/2005
4	ProinsulinIBA 06/2008 - 04/2002
4	Alanine Transaminase (SGPT)IBA 07/2007 - 10/2004
3	Proteins (Proteins, Gene)FDA Link 03/2017 - 10/2003
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2013 - 07/2003
3	ApolipoproteinsIBA 04/2013 - 11/2003
3	HDL LipoproteinsIBA 03/2012 - 09/2002
3	Adenosine Triphosphate (ATP)IBA 03/2006 - 08/2003
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2005 - 10/2004
3	oxidized low density lipoproteinIBA 06/2005 - 10/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2017 - 12/2014
2	hydroxide ionIBA 01/2017 - 09/2009
2	25-hydroxyvitamin DIBA 01/2017 - 09/2009
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2015 - 12/2006
2	CalciumIBA 07/2014 - 03/2007
2	DiureticsIBA 12/2013 - 12/2008
2	AdipokinesIBA 01/2013 - 12/2007
2	Renin InhibitorsIBA 12/2012 - 05/2009
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2012 - 05/2006
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2011 - 04/2002
2	ThiazolidinedionesIBA 01/2010 - 12/2006
2	Blood Glucose (Blood Sugar)IBA 06/2009 - 03/2005
2	Hormones (Hormone)IBA 12/2008 - 07/2005
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2008 - 05/2006
2	AntigensIBA 08/2006 - 10/2002
2	EnzymesIBA 06/2006 - 07/2005
2	Indicators and Reagents (Reagents)IBA 06/2006 - 10/2004
2	Alkaline PhosphataseIBA 11/2005 - 07/2005
2	Apolipoproteins B (ApoB)IBA 10/2004 - 11/2003
2	Plasminogen InactivatorsIBA 07/2004 - 10/2003
1	pro-brain natriuretic peptide (1-76)IBA 10/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2020
1	omega-Chloroacetophenone (Mace)IBA 01/2018
1	AcetylglucosamineIBA 03/2017
1	GalactosamineIBA 03/2017

Therapy/Procedure

8	Therapeutics 05/2013 - 07/2003
6	Glycemic Control 05/2011 - 10/2002
2	Dietary Approaches To Stop Hypertension 09/2021 - 08/2009
2	Transplantation 09/2015 - 12/2012
2	Drug Therapy (Chemotherapy) 12/2006 - 07/2003